4/A

FORM 4/A SUBMISSION

Company: Trevi Therapeutics, Inc.
Filed: July 1, 2022
Period of Report: June 23, 2022
Accession Number: 0001209191-22-040294

View Document ↗ View on SEC.gov ↗